By Elliot N. Fruchtman
ABSTRACT:
This book describes the current state of the pharmaceutical industry and discusses how current government regulations affect scientific innovation. Moreover, the author describes the advantages and disadvantages of various attempts to change the current system. In addition, the author analyzes the Vioxx litigation to illustrate his theory that government regulations restrain innovation and development of new drugs.
ABOUT THE AUTHOR:
Richard A. Epstein has taught at the University of Chicago Law School since 1972. In addition to his position at the University of Chicago, Epstein is currently a Senior Fellow at the Hoover Institution. Previously he has taught at the University of Southern California Law School. Epstein received an AB from Columbia College; a BA from Oxford University; and a LLB from Yale University.
NOTE: Footnotes in this abstract were omitted.
0 Responses to “Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation”